SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Wungki Park · Study

Home/Author

Wungki Park

1 works· latest 2018· 1 institutionscluster: provisionalORCID 0000-0002-8006-3102

h-index1

i101

Citations124

Works here1

18

Most cited in this library

Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients WithEGFR-Mutated Advanced Non–Small Cell Lung Cancer2018 · 124 citations

Works

1 shown

Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients WithEGFR-Mutated Advanced Non–Small Cell Lung Cancer

JAMA Oncology·2018·6 authors·Open access

124citations